The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer
Open accessAbstract
Here, we report that functional heterogeneity of macrophages in cancer could be determined by the nature of their precursors: monocytes (Mons) and monocytic myeloid-derived suppressor cells (M-MDSCs). Macrophages that are differentiated from M-MDSCs, but not from Mons, are immune suppressive, with a genomic profile matching that of M-MDSCs. Immune-suppressive activity of M-MDSC-derived macrophages is dependent on the persistent expression of S100A9 protein in these cells. S100A9 also promotes M2 polarization of macrophages. Tissue-resident- and Mon-derived macrophages lack expression of this protein. S100A9-dependent immune-suppressive activity of macrophages involves transcription factor C/EBPβ. The presence of S100A9-positive macrophages in tumor tissues is associated with shorter survival in patients with head and neck cancer and poor response to PD-1 antibody treatment in patients with metastatic melanoma. Thus, this study reveals the pathway of the development of immune-suppressive macrophages and suggests an approach to their selective targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Self-citationThe Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationFate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Self-citationA Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Research works printed but not linked: 53
- Arts, 2018, BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity, Cell Host Microbe, 23, 89, 10.1016/j.chom.2017.12.010 · DOI · Paper page
- Austermann, 2018, S100 proteins in rheumatic diseases, Nat. Rev. Rheumatol., 14, 528, 10.1038/s41584-018-0058-9 · DOI
- Baratelli, 2005, Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells, J. Immunol., 175, 1483, 10.4049/jimmunol.175.3.1483 · DOI · Paper page
- Bekkering, 2018, Metabolic Induction of Trained Immunity through the Mevalonate Pathway, Cell, 172, 135, 10.1016/j.cell.2017.11.025 · DOI · Paper page
- Bronte, 2019, Deciphering Macrophage and Monocyte Code to Stratify Human Breast Cancer Patients, Cancer Cell, 35, 538, 10.1016/j.ccell.2019.03.010 · DOI
- Cassetta, 2018, Targeting macrophages: therapeutic approaches in cancer, Nat. Rev., 17, 887
- Cheng, 2008, Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein, J. Exp. Med., 205, 2235, 10.1084/jem.20080132 · DOI · Paper page
- Chouaib, 1985, Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression, J. Immunol., 135, 1172, 10.4049/jimmunol.135.2.1172 · DOI · Paper page
- Christ, 2018, Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming, Cell, 172, 162, 10.1016/j.cell.2017.12.013 · DOI · Paper page
- Condamine, 2015, Regulation of tumor metastasis by myeloid-derived suppressor cells, Annu. Rev. Med., 66, 97, 10.1146/annurev-med-051013-052304 · DOI · Paper page
- Cortez-Retamozo, 2012, Origins of tumor-associated macrophages and neutrophils, Proc. Natl. Acad. Sci. USA, 109, 2491, 10.1073/pnas.1113744109 · DOI · Paper page
- Fujita, 2011, COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells, Cancer Res., 71, 2664, 10.1158/0008-5472.CAN-10-3055 · DOI · Paper page
- Gabrilovich, 2017, Myeloid-Derived Suppressor Cells, Cancer Immunol. Res., 5, 3, 10.1158/2326-6066.CIR-16-0297 · DOI · Paper page
- Ghavami, 2009, S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis, Eur. J. Pharmacol., 625, 73, 10.1016/j.ejphar.2009.08.044 · DOI
- Goodwin, 1983, Regulation of the immune response by prostaglandins, J. Clin. Immunol., 3, 295, 10.1007/BF00915791 · DOI · Paper page
- He, 2018, Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation, Nat. Med., 24, 224, 10.1038/nm.4467 · DOI · Paper page
- Kato, 1998, Transgenic mouse model for skin malignant melanoma, Oncogene, 17, 1885, 10.1038/sj.onc.1202077 · DOI · Paper page
- Kerkhoff, 2005, The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2, FASEB J., 19, 467, 10.1096/fj.04-2377fje · DOI · Paper page
- Kielbassa, 2019, Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers, Front. Immunol., 10, 2215, 10.3389/fimmu.2019.02215 · DOI
- Kocieda, 2012, Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells, J. Biol. Chem., 287, 36922, 10.1074/jbc.M112.402958 · DOI
- Kumar, 2016, CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation, Immunity, 44, 303, 10.1016/j.immuni.2016.01.014 · DOI · Paper page
- Langmead, 2012, Fast gapped-read alignment with Bowtie 2, Nat. Methods, 9, 357, 10.1038/nmeth.1923 · DOI · Paper page
- Laoui, 2014, Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population, Cancer Res., 74, 24, 10.1158/0008-5472.CAN-13-1196 · DOI · Paper page
- Lim, 2016, Targeting the CCL2-CCR2 signaling axis in cancer metastasis, Oncotarget, 7, 28697, 10.18632/oncotarget.7376 · DOI · Paper page
- Lu, 2011, Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice, J. Clin. Invest., 121, 4015, 10.1172/JCI45862 · DOI · Paper page
- Manitz, 2003, Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro, Mol. Cell. Biol., 23, 1034, 10.1128/MCB.23.3.1034-1043.2003 · DOI · Paper page
- Mantovani, 2010, Macrophages, innate immunity and cancer: balance, tolerance, and diversity, Curr. Opin. Immunol., 22, 231, 10.1016/j.coi.2010.01.009 · DOI · Paper page
- Mao, 2014, Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity, Clin. Cancer Res., 20, 4096, 10.1158/1078-0432.CCR-14-0635 · DOI · Paper page
- Marigo, 2010, Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor, Immunity, 32, 790, 10.1016/j.immuni.2010.05.010 · DOI · Paper page
- Mastio, 2019, Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs, J. Exp. Med., 216, 2150, 10.1084/jem.20181952 · DOI · Paper page
- Meyer, 2011, Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model, Proc. Natl. Acad. Sci. USA, 108, 17111, 10.1073/pnas.1108121108 · DOI · Paper page
- Milutinović, 2016, Immune memory in invertebrates, Semin. Immunol., 28, 328, 10.1016/j.smim.2016.05.004 · DOI · Paper page
- Murray, 2014, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, 41, 14, 10.1016/j.immuni.2014.06.008 · DOI · Paper page
- Na, 2015, Endogenous prostaglandin E2 potentiates anti-inflammatory phenotype of macrophage through the CREB-C/EBP-β cascade, Eur. J. Immunol., 45, 2661, 10.1002/eji.201545471 · DOI
- Nakanishi, 2013, Multifaceted roles of PGE2 in inflammation and cancer, Semin. Immunopathol., 35, 123, 10.1007/s00281-012-0342-8 · DOI · Paper page
- Nerlov, 2007, The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control, Trends Cell Biol., 17, 318, 10.1016/j.tcb.2007.07.004 · DOI · Paper page
- Obermajer, 2011, Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells, Blood, 118, 5498, 10.1182/blood-2011-07-365825 · DOI · Paper page
- Oppenheim, 2005, Alarmins: chemotactic activators of immune responses, Curr. Opin. Immunol., 17, 359, 10.1016/j.coi.2005.06.002 · DOI · Paper page
- Ortiz, 2014, Myeloid-derived suppressor cells in the development of lung cancer, Cancer Immunol. Res., 2, 50, 10.1158/2326-6066.CIR-13-0129 · DOI
- Ortiz, 2015, Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells, J. Exp. Med., 212, 351, 10.1084/jem.20140835 · DOI
- Pathria, 2019, Targeting Tumor-Associated Macrophages in Cancer, Trends Immunol., 40, 310, 10.1016/j.it.2019.02.003 · DOI · Paper page
- Pinto, 2019, The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer, Front. Immunol., 10, 1875, 10.3389/fimmu.2019.01875 · DOI · Paper page
- Ricciotti, 2013, COX-2, the dominant source of prostacyclin, Proc. Natl. Acad. Sci. USA, 110, E183, 10.1073/pnas.1219073110 · DOI
- Rodriguez, 2005, Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma, J. Exp. Med., 202, 931, 10.1084/jem.20050715 · DOI · Paper page
- Sajti, 2020, Transcriptomic and epigenetic mechanisms underlying myeloid diversity in the lung, Nat. Immunol., 21, 221, 10.1038/s41590-019-0582-z · DOI
- Sanford, 2013, Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis, Clin. Cancer Res., 19, 3404, 10.1158/1078-0432.CCR-13-0525 · DOI · Paper page
- Sinha, 2007, Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells, Cancer Res., 67, 4507, 10.1158/0008-5472.CAN-06-4174 · DOI · Paper page
- Song, 2018, Immune Training Unlocks Innate Potential, Cell, 172, 3, 10.1016/j.cell.2017.12.034 · DOI
- Veglia, 2018, Myeloid-derived suppressor cells coming of age, Nat. Immunol., 19, 108, 10.1038/s41590-017-0022-x · DOI · Paper page
- Veltman, 2010, COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function, BMC Cancer, 10, 464, 10.1186/1471-2407-10-464 · DOI · Paper page
- Wagner, 2019, Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies, J. Immunother. Cancer, 7, 343, 10.1186/s40425-019-0828-1 · DOI
- Wang, 2018, Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies, OncoImmunology, 7, e1494113, 10.1080/2162402X.2018.1494113 · DOI
- Zhao, 2012, S100A9 a new marker for monocytic human myeloid-derived suppressor cells, Immunology, 136, 176, 10.1111/j.1365-2567.2012.03566.x · DOI · Paper page
Cited by
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., Utikal, J., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 489
Immunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
Lin, H., Liu, C., Hu, A., Zhang, D., Yang, H., & Mao, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 392
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Kumari, N., & Choi, S. H. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02272-x · Cited by 315
Therapeutic targeting of tumour myeloid cells
Barry, S. T., Gabrilovich, D. I., Sansom, O. J., Campbell, A. D., & Morton, J. P. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00546-2 · Cited by 305
Self-citationImproving head and neck cancer therapies by immunomodulation of the tumour microenvironment
Ruffin, A. T., Li, H., Vujanovic, L., Zandberg, D. P., Ferris, R. L., & Bruno, T. C. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00531-9 · Cited by 305
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 290
Werba, G., Weissinger, D., Kawaler, E. A., Zhao, E., Kalfakakou, D., Dhara, S., Wang, L., Lim, H. B., Oh, G., Jing, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36296-4 · Cited by 283
Functional states of myeloid cells in cancer
van Vlerken-Ysla, L., Tyurina, Y. Y., Kagan, V. E., & Gabrilovich, D. I. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.009 · Cited by 261
Self-citationChen, Y., Ouyang, Y., Li, Z., Wang, X., & Ma, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188891 · Cited by 165
Martin, O. P., Wallace, M. S., Oetheimer, C., Patel, H. B., Butler, E. C., Wong, L. P., Huang, P., Elbaz, J., Costentin, C., Salloum, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02255-y · Cited by 45
Vidana Gamage, H. E., Shahoei, S. H., Wang, Y., Jacquin, E., Weisser, E., Bautista, R. O., Henn, M. A., Schane, C. P., Nelczyk, A. T., Ma, L., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217042 · Cited by 9
“Interestingly, the mRNA expression of NR0B2 was decreased in bone marrow derived macrophages (BMDMs) derived from monocytic precursors of tumor bearing mice compared to tumor-naïve mice [26,27] (Fig.”
Metadata
- Authors
- Kwak, T., Wang, F., Deng, H., Condamine, T., Kumar, V., Perego, M., Kossenkov, A., Montaner, L. J., Xu, X., Xu, W., Zheng, C., Schuchter, L. M., Amaravadi, R. K., Mitchell, T. C., Karakousis, G. C., Mulligan, C., Nam, B., Masters, G., Hockstein, N., Bennett, J., Nefedova, Y., & Gabrilovich, D. I.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 33
- Issue
- 13
- Pages
- 108571
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W3116206322
- Cited by
- 178
- References
- 18
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 8 d)
- Funders
- National Cancer Institute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.